Cure = Research + Innovation ²

AIDS Research Alliance helped to develop about half of current anti-HIV drugs. Today, ARA is developing a new compound called prostratin, which targets latent HIV—the virus not killed by existing therapies. If approved by the FDA, this drug will unveil an entirely new way to treat HIV/AIDS, and it may lead to a comprehensive cure strategy.

AIDS Research Alliance is the only HIV research initiative with a drug in development that targets latent HIV. Click here to learn more about prostratin.

The landscape of HIV science is changing.
A number of U.S. HIV experts agree: a cure for AIDS is probably beyond the reach of the current research establishment. Instead, they believe a cure will spring from a small, flexible research organization — one that thinks “outside the box.” AIDS Research Alliance is just such an organization.

ARA is an independent, privately-funded research initiative group. We are not motivated by “making a profit” on new treatments. And we aren’t limited by government’s bureaucratic constraints. This gives ARA’s scientists the freedom to explore the best and brightest ideas.

An Expanding Focus
As the disease changes, so does the scope of our HIV/AIDS research. We expand our research to follow the course of this epidemic. Click here to see ARA’s main areas of focus.

Successes in the Fight Against AIDS
Since 1989, AIDS Research Alliance has studied nearly half of the current FDA-approved HIV drugs. Our efforts were especially pivotal in a number of them, including:

• Nelfinavir (Viracept™), a protease inhibitor regarded as an effective and well-tolerated anchor drug in many triple therapy combinations.
  
• Tenofovir (Viread™), the first drug indicated for patients in a “salvage situation” whose immune systems do not respond to any other HIV drugs.
  
• Sustained release d4t (2004) that simplifies drug regimens with once-a-day dosing.
  
• Integrase Inhibitor (Raltegavir), a new class of anti-HIV drugs
  
• Serostim, a growth hormone for treatment of HIV-associated lipodystophy

Click here to read more about ARA’s accomplishments and our history of scientific advances.
Learn more about ARA’s Current Research Initiatives.